Please login to the form below
academic research
This page shows the latest academic research news and features for those working in and with pharma, biotech and healthcare.
Microfoundations matter
In the jargon of my academic research, you need to modify your routineome by engineering its microfoundations.
Latest news
-
Cancer Research Horizons and the Karolinska Institutet announce five-year strategic partnership
of academic cancer research into improved treatments for patients. ... Martin Bergö, academic vice president for research said: “We are particularly excited by the opportunities that will arise from our new partnership with Cancer Research Horizons
-
New study identifies gene associated with strong immune response to COVID-19 vaccines
The research provides some of the first evidence of a relationship between genetic factors and the way that people’s immune systems respond to COVID-19 vaccines. ... Dr Alexander Mentzer, National Institute for Health and Care Research academic
-
Elsevier launches global collaboration to ‘navigate’ changing landscape of scientific research
The initiative will examine the increased public attention on science during the COVID-19 pandemic and its impact on the academic research community. ... The initiative will examine how researchers have experienced the increased public attention on
-
Roche’s Polivy receives EC approval for lymphoma therapy
The study continues to be conducted in collaboration with The Lymphoma Study Association and The Lymphoma Academic Research Organisation.
-
SOLVE FSHD announces the appointment of Dr Eva Chin as its executive director
Dr Chin’s has an extensive background in the academic and pharmaceutical industries, having previously held positions at Pfizer, the University of Maryland, MyoTherapeutics, Cytokinetics and NMD Pharma. ... At Pfizer, her career evolved from academic
More from news
Approximately 3 fully matching, plus 74 partially matching documents found.
Latest Intelligence
-
Next congress, please: making the most of virtual pharmaceutical congresses
Check. Treatment and therapy area education? Check. Academic research presentations? Check.
-
Changing an organisation’s microfoundations – why capabilities count
Figure 1. In my academic field of Generalized Darwinism, life sciences companies roam the healthcare ecosystem like animals in a jungle. ... In my academic research, I draw parallels between biological proteins and business capabilities, because they are
-
Cross-functional alignment
That why it’s been central to my research agenda for more than 20 years. ... Casus belli, casus pax. The next phase of my research was, in academic speak, a comparative research question.
-
Creating patient support programmes that help patients thrive
However, companies frequently struggle to effectively apply learnings from healthcare and behaviour science research in an industry setting. ... Their academic work includes healthcare research, and provision of health behaviour change and psychological
-
How the Royal Society’s EiR programme can help to drive UK innovation
I was struck by the extensive experience/ skill set of the delegates and their commitment to nurturing and directing their respective universities along the road map to commercialising academic research. ... Not all universities need or are willing to
More from intelligence
Approximately 0 fully matching, plus 37 partially matching documents found.
Latest appointments
-
New faces at Healthware Group and HRW
HRW. Healthcare Research Worldwide (HRW) has expanded their applied behavioural science team with two new. ... In addition to an exemplary academic record, Emma has gathered research experience via internships with the Qualitative Research Team at the
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more
Brown succeeds Graham Boulnois, the group’s founding chairman, and brings experience of academic research, biotech, big pharma and US venture capital to the role. ... Most recently, Brown was the chief executive officer of KWS BioTest, a specialist
-
José Baselga joins BMS’ board of directors
He brings more than 30 years of clinical and research experience to his new position on the board, and his career history has seen him serve as president for the American ... Giovanni Caforia, chairman and chief executive officer of BMS, said: “José
-
Professor Carole Longson moves from NICE to the ABPI
Her scientific research and academic experience, along with her integrity, perspective and vision can really help us continue to transform the pharmaceutical industry in the UK.”. ... Longson brings research, academic and pharmaceutical industry
-
Novartis appoints Shaun Coughlin to lead its US biomedical research institute
The renowned academic joins as the pharma firm's global head of cardiovascular and metabolism. ... He joins the pharma giant from the University of California San Francisco’s (UCSF) cardiovascular research centre, where he was previously a director.
More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Article: How behavioural economics can help you build better brand communications
It’s a biological algorithm developed by Dragonfly AI, and is based on years of academic research into how the brain responds to visual content across five neural pathways. ... Based on years of academic research into the known meanings of instinctive
-
Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic
Among healthcare institutions, academic medical research institutions are the most trusted.
-
Opening up about patient engagement
Health research organisations, academic research centres and charities make ‘How to get involved’ a prominent statement on their websites. ... There are challenges at all stages of research and medicine development, but so few of them get voiced to
-
If our patients are diverse, why are clinical trials so white?
As it happens, clinical research is more likely to happen at research or academic institutions. ... Patients in marginalised or vulnerable communities may also mistrust medical or research systems.
-
Turning learning into action: The challenge of behaviour change
Thankfully, there has been an increasing body of academic research in modelling human behaviour over the past few years, including the adaptation of the COM-B model.
More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
